SLAM BioTherapeutics
- Biotech or pharma, therapeutic R&D
Oncology Biotech developing first-in-class antibodies, ADCs and bispecifics to conquer life-threatening cancers and unmet needs such as AML, MDS, CTCL and FL.
June 16-19, 2025
Boston Convention & Exhibition Center
Oncology Biotech developing first-in-class antibodies, ADCs and bispecifics to conquer life-threatening cancers and unmet needs such as AML, MDS, CTCL and FL.